Evotec (EVT) – cijena dionice i vijesti

Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of 31 December 2021 Evotec had a market capitalization of €7.5 billion and a pipeline of more than 130 partnered programs in discovery, pre-clinical development and clinical development. The company's 4,200+ employees work across a number of therapeutic areas including CNS/neurology, metabolic diseases, Cancer, and inflammatory and infectious diseases. It has long-term discovery alliances with Bristol Myers Squibb, Bayer, Sanofi, Boehringer Ingelheim, the CHDI Foundation, Lilly, Takeda, Sernova, and more. On 28 October 2009 the company was listed on the TecDAX index, which tracks the performance of the 30 largest German companies from the technology sector. On 24 September 2018 Evotec joined the MDAX index, following a rule change that enabled dual listing. The MDAX tracks 60 Prime Standard shares from sectors excluding technology. Wikipedia

Evotec – informacije

Glavni izvršni direktor-

Zaposlenici4,46 tis.

Osnovano1993

Sjedište-

Sektor-

Web-lokacijaevotec.com

Sve vrijednosti su u valuti EUR	ruj 2025.	pro 2025.	ožu 2026.	lip 2026.
Prihod	163,89 mil.	253,27 mil.	156,64 mil.	143,48 mil.
Trošak prodane robe	163,95 mil.	174,81 mil.	158,21 mil.	145,06 mil.
Trošak prihoda	163,95 mil.	174,81 mil.	158,21 mil.	145,06 mil.
Izdaci za istraživanje i razvoj	8,71 mil.	9,83 mil.	10,08 mil.	10,26 mil.
Ukupni izdaci za istraživanje i razvoj	-	-	-	-
Izdaci za prodaju, opći i administrativni izdaci	42,31 mil.	44,35 mil.	43,79 mil.	39,29 mil.
Poslovni rashod	43,53 mil.	55,25 mil.	44,85 mil.	87,74 mil.
Ukupni poslovni rashodi	207,48 mil.	230,06 mil.	203,07 mil.	232,80 mil.
Poslovni prihod	−43,59 mil.	23,21 mil.	−46,42 mil.	−89,32 mil.
Ostali neposlovni prihod	1,19 mil.	−33,96 mil.	1,89 mil.	−839,00 tis.
Zarada prije poreza uključujući neuobičajene stavke	−42,96 mil.	29,46 mil.	−122,18 mil.	−48,12 mil.
Zarada prije poreza isključujući neuobičajene stavke	−43,36 mil.	18,35 mil.	−47,40 mil.	−94,00 mil.
Izdaci za porez na dohodak	127,00 tis.	14,84 mil.	−244,00 tis.	−1,47 mil.
Efektivna porezna stopa	−0,30 %	50,37 %	0,20 %	3,06 %
Ostali poslovni rashodi	−7,50 mil.	1,07 mil.	−9,02 mil.	38,20 mil.
Neto dohodak	−43,09 mil.	14,62 mil.	−121,94 mil.	−46,65 mil.
Neto profitna marža	−26,29 %	5,77 %	−77,84 %	−32,51 %
Zarada po dionici	−0,24	-	-	-
Prihod od kamata i ulaganja	841,00 tis.	11,84 mil.	-	-
Izdaci za kamate	−2,28 mil.	-	−2,58 mil.	−2,97 mil.
Neto izdaci za kamate	−1,44 mil.	11,84 mil.	−2,58 mil.	−2,97 mil.
Troškovi amortizacije i otpisa	-	-	-	-
Dobit prije kamata, poreza i amortizacije	−18,27 mil.	41,91 mil.	−22,60 mil.	−64,88 mil.
Dobit ili gubitak od prodaje imovine	-	-	-	-

Finance

Pitajte bilo što